why choose us

First received: April 14, 2023

Clinical Trial: DIGITAL Biomarker: Blood Based Biomarkers in the Primary Care Setting for Alzheimer's Disease

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Mild Cognitive Impairment

Study Type: OBSERVATIONAL


Official Title: DIGITAL Biomarker: Blood Based Biomarkers in the Primary Care Setting for Timely and Accurate Diagnosis of Alzheimer's Disease

Brief Summary: The primary objective of this study is to evaluate the feasibility of implementing blood-based biomarker testing for amyloid positivity designed to aid the early detection of Alzheimer's Disease and Related Dementia (ADRD) in patients 65+ including the rate that patients and providers follow up abnormal blood-based biomarker testing.

Read more